US9675563B2ActiveUtilityPatentIndex 35

Method for adjunctive treatment of cancer metastasis by using lycogen

Assignee: ASIA-PACIFIC BIOTECH DEV INCPriority: Jul 30, 2015Filed: Jul 28, 2016Granted: Jun 13, 2017

Est. expiryJul 30, 2035(~9.1 yrs left)· nominal 20-yr term from priority

Inventors:LIU WEN-SHENG CHANG FU-HSIN HSIAO YA-FEN

A61K 31/121A61K 31/08A61K 31/015A61K 31/01A61K 35/74A61P 35/04A61P 35/00A61P 3/10A61P 9/00A61P 17/02A61K 31/513

PatentIndex Score

Cited by

References

Claims

Abstract

The present invention relates to a method for adjunctive treatment of cancer by using a Lycogen composition to inhibit metastasis, comprising administering a Lycogen composition to the subject, wherein the Lycogen composition comprises an effective amount of a Lycogen extract, wherein the Lycogen extract comprises active ingredients selected from ζ-carotene, neurosporene, spheroidenone, methoxyneurosporene or a combination thereof.

Claims

exact text as granted — not AI-modified

What is claimed is: 
     
       1. A method for adjunctively treating cancer metastasis in a subject, comprising administering a Lycogen composition to the subject, wherein the Lycogen composition comprises an effective amount of a Lycogen extract. 
     
     
       2. The method of  claim 1 , wherein the Lycogen extract comprises active ingredients selected from ζ-carotene, neurosporene, spheroidenone, methoxyneurosporene or a combination thereof. 
     
     
       3. The method of  claim 1 , wherein the Lycogen extract is extracted from a mutant photosynthetic bacterium. 
     
     
       4. The method of  claim 3 , wherein the mutant photosynthetic bacterium is  Rhodobacter sphaeroides , which is deposited under deposit number DSM 25056. 
     
     
       5. The method of  claim 1 , wherein the Lycogen composition has adjunctive effects on cell proliferation, cell migration and/or angiogenesis.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.